Al-Dughaishi, M., A. Shalaby, K. Al-Ribkhi, A. Boudaka, M.-R. Boulassel, and J. Saleh. “The Value of Programmed Death Ligand 1 Expression in Cancer Patients Treated With Neoadjuvant Chemotherapy”. Sultan Qaboos University Medical Journal, vol. 19, no. 4, Dec. 2019, pp. e277-283, doi:10.18295/squmj.2019.19.04.002.